Filter
109
Filtered Results: 109
Text search:
ИППП
Featured
Recommendations
13
New Publications
34
Language
Document type
No document type
69
Guidelines
29
Studies & Reports
7
Training Material
1
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
4
Latin America and the Carribbean
3
India
3
Zambia
2
Kenya
1
Senegal
1
Global
1
USA
1
South Africa
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
HIV & STI
107
Pediatrics
7
Maternal Health
7
TB
5
Paediatrics
4
Clinical Training
2
Hepatitis
2
Dermatology
2
Maternal & Child Health
2
Policies & Guidelines HIV & TB
2
Studies & Reports
2
Statistics
2
Communicable Diseases
2
Communicable Diseases
1
Online Courses & Platforms
1
Humanitarian Aid
1
Virology
1
Chagas
1
Clinical Guidelines
1
Guidelines
1
Capacity Building
1
General Guidelines
1
Needs Assessment
1
Gynaecology & Obstetrics
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Antiretroviral Treatment ART
15
Treatment Guidelines HIV
11
Treatment & Prevention
10
Clinical Aspects
8
HIV testing & services
7
Opportunistic Infections
7
Co-Morbidities (except TB)
7
ART Drug Resistance
6
Women
5
Prevention of mother-to-child transmission (PMTCT)
4
HIV in Key Populations
4
Clinical Aspects, Treatment & Prevention
2
Prevention Guidelines
2
HIV / AIDS
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
HIV and coinfection
2
Assessment & Studies
1
Surveillance
1
HIV surveillance
1
Humanitarian Settings
1
Men who have sex with men (MSM)
1
HIV
1
Others
1
Sex Worker
1
General
1
HIV and COVID-19
1
COVID-19
1
Zoonoses
1
NTDs
1
Chagas
1
Access to treatment and laboratory
1
Online courses
1
General Aspects
1
Prophylactic Treatment
1
Latin America & the Carribean
1
HIV / AIDS
1
Testing Guidelines
1
TB/HIV Coinfection
1
HIV service delivery
1
TB
1
July 2019
Policy brief
HIV Treatment
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
ПРактИЧеское РукоВодстВо для соВместных меРоПРИятИй.
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
HIV Toolbox
recommended
We have created a special Toolbox on HIV, please click here to see all guidelines, manuals, reports & studies
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Testing men for HIV during their partner’s pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HIV-negative ...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...
Men experience increased risk of morbidity and mortality across all ten major contributors to poor health and continue to lag behind women regarding HIV services and other health outcomes. Globally, men now account for the majority of new HIV infections. In 2022, only 72% of men living with HIV (age...
